#ISC23
Access Virtual Experience
Access ePosters
Privacy Policy
Late-Breaking Science
Daily Coverage
Industry Highlights
Program
Late-Breaking Science
Late Breaking Science: Improving stroke thrombolysis, comparing tenecteplase and alteplase, and treating cognitive decline after lacunar stroke
Late-Breaking Science
Late-Breaking Science: SPAN results, monitoring ischemic stroke in small- and large-vessel disease and positive neuroprotective effects from aptamer
ISC23
Stroke
simultaneous publications from ISC 2023
Home
Late-Breaking Science for #ISC23
Late-Breaking Science
Late-Breaking Science: BEST-II, CATIS-2, ANGEL-ASPECT, SELECT 2, ARAMIS, RESCUE BT2 and CMOSS
Daily Coverage
Schedule of Main Events
Each day of the #ISC23 conference features a Main Event, featuring named lectures and late-breaking science.
Late-Breaking Science
Trials’ results shed light on new technology for preventing stroke, best practices and devices for LVO retrieval, the effectiveness of antiplatelet therapy with the addition of cilostazol and mechanical thrombectomy in pediatric patients with LVO
Sponsored
NeuroLogica brings you the next generation SmartMSU™
Late-Breaking Science
Trials’ results highlight the cost-effectiveness of mobile stroke units and point to advancements in treatment approaches for patients with LVO, cerebral venous thrombosis and cerebral arteriovenous malformation
Daily Coverage
Endovascular therapy, tirofiban for LVO and periodontal care highlight late-breaking science
Investigators share their late-breaking science findings during the ISC 2022 Opening Session.
Late-Breaking Science
Main Events to present late-breaking science
The latest stroke science research will be presented in New Orleans.
ISC21
Late-Breaking Science: New data in clot removal, stroke patients with COVID-19
ISC21
Roos: MR CLEAN-NO IV results
Investigator Yvo Roos, MD, PhD, shares findings from the latest trial.
ISC21
Nogueira: SHRINE results
Investigator Raoul Gomes Nogueira discusses results from his study comparing direct MT and bridging IVT/MT and a personalized approach to treatment for large vessel occlusion stroke.
ISC21
Late-Breaking Science: Trials’ results point to advancements in treatment approaches for patients with ischemic stroke
ISC21
ANGIO-CAT Late-Breaking Science results
Manuel Requena, MD, PhD, and Marc Ribo, MD, PhD, co-investigators of ANGIO-CAT, discuss their findings.
ISC21
Late-Breaking Science: Sending patients from ambulance directly to angio suite improves outcomes
ISC21
ISC 21 honors awardees
ISC21
Meet the Trialist
ISC21
How to navigate posters at #ISC21
ISC21
#ISC21 to deliver powerful Late-Breaking Science
ISC21
ISC 2022 award nominations
ISC21
Call for ISC 22 science
ISC21
Late-Breaking Science to headline #ISC21 Main Events
